Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| RXT | PRESS-RELEASE | mixed | 5/10 | Rackspace Technology reported Q1 2026 revenue of $678M (beat $660.8M consensus) and GAAP EPS of $0.03 (beat -$0.03 conse | May 7, 2026 |
| ALXO | PRESS-RELEASE | neutral | 4/10 | ALX Oncology presented exploratory Phase 1b/2 data at ESMO Breast Cancer 2026 showing that evorpacept plus zanidatamab a | May 7, 2026 |
| SLDB | PRESS-RELEASE | bullish | 7/10 | Solid Biosciences dosed the first participant in its Phase 3 IMPACT DUCHENNE trial for SGT-003, a gene therapy for Duche | May 7, 2026 |
| PRME | PRESS-RELEASE | bearish | 5/10 | Prime Medicine reported Q1 2026 EPS of -$0.28, missing consensus of -$0.25 by 12%, and collaboration revenue of $856K ve | May 7, 2026 |
| SPRY | PRESS-RELEASE | neutral | 1/10 | ARS Pharmaceuticals, Inc. announced it will host a conference call on May 15, 2026 to discuss its Q1 2026 results. | May 7, 2026 |
| CELC | PRESS-RELEASE | neutral | 1/10 | Celcuity Inc. announced it will report its Q1 2026 results on May 14, 2026. | May 7, 2026 |
| FLNA | PRESS-RELEASE | neutral | 4/10 | Filana Therapeutics reported Q1 2026 net loss of $0.21 per share, beating consensus of -$0.23 by 8.7%, driven by reduced | May 7, 2026 |
| CMT | PRESS-RELEASE | mixed | 6/10 | Core Molding Technologies reported Q1 2026 GAAP EPS of $0.07, well below the $0.22 consensus, and revenue of $58.6M, sli | May 7, 2026 |
| PRAX | PRESS-RELEASE | bullish | 8/10 | Praxis Precision Medicines reported Q1 2026 EPS of -$3.20 (GAAP), a 2.7% beat vs consensus of -$3.68, but the headline i | May 7, 2026 |
| MDWD | PRESS-RELEASE | neutral | 1/10 | MediWound Ltd. announced it will report its Q1 2026 results on May 27, 2026. | May 7, 2026 |
| DGNX | PRESS-RELEASE | neutral | 5/10 | Diginex announced an all-share proposed acquisition of Resulticks, a real-time AI customer intelligence firm, to integra | May 7, 2026 |
| GCMG | PRESS-RELEASE | bullish | 7/10 | GCM Grosvenor reported Q1 2026 EPS of $0.31, a 70.3% beat vs the $0.18 consensus, though revenue details were not provid | May 7, 2026 |
| ACFN | PRESS-RELEASE | bearish | 5/10 | Acorn Energy reported Q1 2026 revenue of $2.23M, down 28.1% YoY due to a 55.7% decline in hardware revenue from a large | May 7, 2026 |
| VCEL | PRESS-RELEASE | bullish | 8/10 | Vericel reported Q1 2026 revenue of $68.4M (+30% YoY) and GAAP EPS of -$0.12 (vs consensus -$0.16, a 25% beat on the los | May 7, 2026 |
| ZENA | PRESS-RELEASE | neutral | 5/10 | ZenaTech signed a binding agreement to acquire an Australian land surveying and spatial services firm, marking its 22nd | May 7, 2026 |
| MOB | PRESS-RELEASE | neutral | 3/10 | Mobilicom announced its participation in XPONENTIAL 2026 and Loitering Munitions USA, with CEO Oren Elkayam presenting o | May 7, 2026 |
| AFCG | PRESS-RELEASE | bullish | 7/10 | AFCG reported Q1 2026 GAAP NII of $0.21 per share, well above the $0.18 consensus estimate, driven by strong investment | May 7, 2026 |
| INSE | PRESS-RELEASE | bullish | 6/10 | Inspired Entertainment reported Q1 2026 revenue of $57.2M (down 5% YoY due to divestitures) but GAAP EPS of -$0.02 beat | May 7, 2026 |
| QRED | PRESS-RELEASE | mixed | 5/10 | QuasarEdge Acquisition Corp (QRED) entered a non-binding LOI to acquire Robseek Intelligence Inc. in a share-for-share e | May 7, 2026 |
| MKTW | PRESS-RELEASE | mixed | 7/10 | MarketWise reported Q1 2026 GAAP net loss of $0.6M ($0.23 diluted EPS) vs $16.8M net income ($0.41 diluted EPS) a year a | May 7, 2026 |
| TRDA | PRESS-RELEASE | mixed | 6/10 | Entrada Therapeutics reported Q1 2026 results with a net loss of $39.7M ($0.95/share), beating consensus EPS of -$1.06 b | May 7, 2026 |
| XMTR | PRESS-RELEASE | bullish | 7/10 | Xometry announced a strategic partnership with Siemens to embed its AI-native manufacturing intelligence into Siemens Xc | May 7, 2026 |
| LQDT | PRESS-RELEASE | bullish | 7/10 | Liquidity Services reported Q2 FY2026 (Mar 31, 2026) results with GAAP EPS of $0.23 (up 5% YoY) and Non-GAAP Adjusted Di | May 7, 2026 |
| RPC | PRESS-RELEASE | neutral | 4/10 | Ridgepost Capital reported record fee-paying AUM of $31B (+18% YoY) and $2B in gross capital raised for Q1 2026, but the | May 7, 2026 |
| PLTK | PRESS-RELEASE | mixed | 6/10 | Playtika reported Q1 2026 revenue of $744.7M (beat $694.7M consensus) but GAAP EPS of -$0.15 missed the $0.12 estimate, | May 7, 2026 |
| FENC | PRESS-RELEASE | neutral | 1/10 | Fennec Pharmaceuticals Inc. announced it will report its Q1 2026 results on May 14, 2026. | May 7, 2026 |
| HIMX | PRESS-RELEASE | bullish | 7/10 | Himax reported Q1 2026 EPS of $0.046, beating consensus of $0.03 by 53%, and revenue of $199.0M slightly above the $195. | May 7, 2026 |
| STTK | PRESS-RELEASE | bullish | 5/10 | Shattuck Labs reported Q1 2026 EPS of -$0.12, beating consensus of -$0.13 by 9.1%, with zero revenue as expected. The co | May 7, 2026 |
| GTN | PRESS-RELEASE | neutral | 2/10 | Gray Media declared a quarterly cash dividend of $0.08 per share, payable June 30, 2026. This is a routine capital retur | May 7, 2026 |
| TE | PRESS-RELEASE | neutral | 1/10 | T1 Energy Inc. announced it will report its Q1 2026 results on May 12, 2026. | May 7, 2026 |